Advertisement

Surgery pp 1773-1786 | Cite as

Pancreas and Islet Transplantation

  • Robert C. Harland
  • Marc R. Garfinkel

Abstract

IDiabetes mellitus is a systemic disease that currently affects 6% of the population and ranks as the third most common disease.1 In the United States, 1 to 2 million of these people have type 1 diabetes mellitus, previously referred to as juvenile-onset diabetes.2 Type 1 diabetes is characterized by deficient insulin production due to destruction of insulin-producing beta cells in the pancreas. The etiology of this cell destruction has not been fully elucidated, but autoimmune attack, genetic factors, and environmental influences, including infectious agents, have all been implicated. Some insulin-deficient patients have glucose intolerance from loss of pancreas function following pancreatitis, with or without surgical pancreatic resection. Such patients are also insulin deficient and have many of the characteristics and complications seen in patients with autoimmune type 1 diabetes.

Keywords

Islet Transplantation Pancreas Transplant Insulin Independence Pancreas Graft Pancreas Allograft 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Harris M, Hadden WC, Knowles WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in the U.S. population aged 20—74 years. Diabetes 1987;36:523–534.PubMedCrossRefGoogle Scholar
  2. 2.
    Libman I, Songer T, Lapote R. How many people in the U.S. have IDDM? Diabetes Care 1993;16:841–842.PubMedGoogle Scholar
  3. 3.
    National Diabetes Data Group, National Institutes of Health. Diabetes in America, 2nd ed. Bethesda, MD: National Institutes of Health; 1995.Google Scholar
  4. 4.
    Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med 1993;328:1676–1684.PubMedCrossRefGoogle Scholar
  5. 5.
    Selby JV, Fitzsimmons SC, Newman JM, et al. The natural history and epidemiology of diabetic nephropathy: implications for prevention and control. JAMA 1990;263:1954–1960.PubMedCrossRefGoogle Scholar
  6. 6.
    American Diabetes Association. Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care 1998;21:296–309.CrossRefGoogle Scholar
  7. 7.
    The Diabetes and Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–986.CrossRefGoogle Scholar
  8. 8.
    Munger B. Morphologic characterization of islet cell diversity. In: Cooperstein S, Watkins D, eds. The Islets of Langerhans: Biochemistry, Physiology, and Pathology. New York: Academic Press; 1981:3–34.Google Scholar
  9. 9.
    Gruessner AC, Sutherland DER. Analysis of United States and non-U. S. pancreas transplants as reported to the International Pancreas Transplant Registry (IPTR) and to the United Network for Organ Sharing (UNOS). Clinical Transplants 1998. Los Angeles: UCLA Tissue Typing Laboratory; 1999:1–19.Google Scholar
  10. 10.
    Sollinger HW, Ploeg RJ, Eckhoff DE, et al. Two hundred consecutive simultaneous pancreas-kidney transplants with bladder drainage. Surgery 1993;114:736–744.PubMedGoogle Scholar
  11. 11.
    Kuo PC, Johnson LB, Schweitzer EJ, et al. Solitary pancreas allografts. Arch Surg 1997;132:52–57.PubMedGoogle Scholar
  12. 12.
    Venström JM, McBride MA, Rother KI, et al. Survival after pancreas transplantation in patients with diabetes and preserved kidney function. JAMA 2003;290:2817–2833.PubMedCrossRefGoogle Scholar
  13. 13.
    Gruessner RWG, Sutherland DER, Gruessner AC. Mortality assessment for pancreas transplants. Am J Transplant 2005;4:2018–2026.CrossRefGoogle Scholar
  14. 14.
    Stratta RJ, Taylor RJ, Larsen JL, Cushing K. Pancreas transplantation. Int J Pancreatol 1995;17:1–13.PubMedGoogle Scholar
  15. 15.
    Schweitzer Ef, Anderson L, Kuo PC, et al. Safe pancreas transplantation in patients with coronary artery disease. Transplantation 1997;63:1294–1299.PubMedCrossRefGoogle Scholar
  16. 16.
    Odorico JS, Heisey DM, Voss BJ, et al. Donor factors affecting outcome after pancreas transplantation. Transplant Proc 1998;30:276–277.PubMedCrossRefGoogle Scholar
  17. 17.
    Doudzdjian V, Gugliuzza KG, Fish JC. Multivariate analysis of donor risk factors for pancreas allograft failure after simultaneous pancreas-kidney transplantation. Surgery 1995;118:73–81.CrossRefGoogle Scholar
  18. 18.
    Gores PF, Gillingham KJ, Dunn DL, Moudry-Munns KC, Najarian JS, Sutherland DER. Donor hyperglycemia as a minor risk factor and immunologic variables as major risk factors for pancreas allograft loss in multivariate analysis of a single institution’s experience. Ann Surg 1992;215:217–230.PubMedCrossRefGoogle Scholar
  19. 19.
    Hesse UJ, Sutherland DER. Influence of serum amylase and plasma glucose levels in pancreas cadaver donors on graft function in recipients. Diabetes 1989;38(suppl 1):1–3.PubMedGoogle Scholar
  20. 20.
    Bunzendahl H, Ringe B, Meyer HJ, Gubernatis G, Pichlmayr R. Combination harvesting procedure for liver and whole pancreas. Transpl Int 1988;1:99–102.PubMedGoogle Scholar
  21. 21.
    Dunn DL, Morel P, Schlumpf R, et al. Evidence that combined procurement of pancreas and liver grafts does not affect transplant outcome. Transplantation 1991;51:150–157.PubMedGoogle Scholar
  22. 22.
    Belzer FO, D’Alessandro AM, Hoffman RM, et al. The use of UW solution in clinical transplantation. Ann Surg 1992;215:579–585.PubMedCrossRefGoogle Scholar
  23. 23.
    Englesbe MJ, et al. Early pancreas outcomes with histidinetryptophan-ketoglutarate preservation: a multicenter study. Transplantation 2006;82:136–139.PubMedCrossRefGoogle Scholar
  24. 24.
    Humar A, Gruessner RWG, Sutherland DER. Living related donor pancreas and pancreas-kidney transplantation. Br Med Bull 1997;53:879–891.PubMedGoogle Scholar
  25. 25.
    Seaquist ER, Robertson RP. Effects of hemipancreatectomy on pancreatic alpha and beta cell function in healthy human donors. J Clin Invest 1992;89:1761–1766.PubMedCrossRefGoogle Scholar
  26. 26.
    Gruessner RW, Kendall DM, Drangstveit MB, Gruessner AC, Sutherland DE. Simultaneous pancreas-kidney transplantation from live donors. Ann Surg 1997;226:471–480.PubMedCrossRefGoogle Scholar
  27. 27.
    Zieliski A, et al. Simultaneous pancreas-kidney transplant from living related donor: a single-center experience. Transplantation 2003;76:547–552.CrossRefGoogle Scholar
  28. 28.
    Nymann T, Hathaway DK, Shokouh-Amiri MH, et al. Patterns of acute rejection in portal-enteric versus systemic-bladder pancreas-kidney transplantation. Clin Transplant 1998;12:175–183.PubMedGoogle Scholar
  29. 29.
    Stratta RJ, Gaber AO, Shokouh-Amiri MH, et al. A 9-year experience with 126 pancreas transplants with portal enteric drainage. Arch Surg 2001;136:1141–1149.PubMedCrossRefGoogle Scholar
  30. 30.
    Gruessner AC, Sutherland DER. Pancreas transplants for United States and non-U. S. cases as reported to the International Pancreas Transplant Registry (IPTR) and to the United Network for Organ Sharing (UNOS). Clinical Transplants 1997. Los Angeles: UCLA Tissue Typing Laboratory; 1998:40–45.Google Scholar
  31. 31.
    Gaber AO, Shokouh-Amiri MH, Hathaway D, et al. Results of pancreas transplantation with portal venous and enteric drainage. Ann Surg 1995;221:613–624.PubMedCrossRefGoogle Scholar
  32. 32.
    Losanoff JE, Harland RC, Thistlethwaite JR, et al. Omega jeju-noduodenal anastomosis for pancreas transplant. J Am Coll Surg 2005;202:1021–1024.CrossRefGoogle Scholar
  33. 33.
    Demartinesa N, Schiessera M, Claviena PA. An evidence-based analysis of simultaneous pancreas-kidney and pancreas transplantation alone. Am J Transplant 2005;5:2688–2697.CrossRefGoogle Scholar
  34. 34.
    Sollinger HW, Stratta RJ, D’Alessandro AM, Kalayoglu M, Pirsch JD, Belzer FO. Experience with simultaneous pancreas-kidney transplantation. Ann Surg 1988;208:475–483.PubMedCrossRefGoogle Scholar
  35. 35.
    Rosen B, Frohnert PP, Velosa JA, et al. Morbidity of pancreas transplant during cadaveric renal transplantation. Transplantation 1991;51:123–127.PubMedCrossRefGoogle Scholar
  36. 36.
    Stratta RJ, Taylor RJ, Lowell JA, et al. OKT3 induction in 100 consecutive pancreas transplants. Transplant Proc 1994;55:509–516.Google Scholar
  37. 37.
    Sutherland DER, Gruessner A. Pancreas transplantation as reported to the United Network for Organ Sharing and analyzed by the International Pancreas Transplant Registry. Clinical Transplants 1995. Los Angeles: UCLA Tissue Typing Laboratory; 1996:49.Google Scholar
  38. 38.
    Kuo PC, Wong J, Schweitzer EJ, Johnson LB, Lim JW, Bartlett ST. Outcome after splenic vein thrombosis in the pancreas allograft. Transplantation 1997;64:933–935.PubMedCrossRefGoogle Scholar
  39. 39.
    Troppman C, Gruessner MS, Dunn DL, Sutherland DER, Gruessner RWG. Surgical complications requiring early relaparotomy after pancreas transplantation. Ann Surg 1998;227:255–268.CrossRefGoogle Scholar
  40. 40.
    DeVito-Haynes LD, Jankowska-Gan E, Sollinger HW, Knechtle SJ, Burlingham WJ. Monitoring of kidney and simultaneous pancreas-kidney transplantation rejection by release of donor-specific, soluble HLA class I. Hum Immunol 1994;40:191–201.PubMedCrossRefGoogle Scholar
  41. 41.
    Elmer DS, Hathaway DK, Bashar Abdulkarim A, et al. Use of glucose disappearance rates (kG) to monitor endocrine function of pancreas allografts. Clin Transplant 1998;12:56–64.PubMedGoogle Scholar
  42. 42.
    Drachenberg CB, Papadimitriou JC, Klassen DK, et al. Evaluation of pancreas transplant needle biopsy. Transplantation 1997;63:1579–1586.PubMedCrossRefGoogle Scholar
  43. 43.
    Sutherland DER, Sibley RK, Xu XZ, et al. Twin-to-twin pancreas transplantation: reversal and reenactment of the pathogenesis of type 1 diabetes. Trans Assoc Am Phys 1984;97:80–87.PubMedGoogle Scholar
  44. 44.
    Sutherland DER, Goetz FC, Sibley RK. Recurrence of disease in pancreas transplants. Diabetes 1989;38:85–87.PubMedGoogle Scholar
  45. 45.
    Sutherland DER, Gruessner RWG, Dunn DL, Moudry-Munns KC, Gruessner AC, Najarian JS. Pancreas transplants from living related donors. Transplant Proc 1994;26:443–445.PubMedGoogle Scholar
  46. 46.
    Benedetti E, Dunn T, Massad MG, et al. Successful living related simultaneous pancreas-kidney transplant between identical twins. Transplantation 1999;67:915–934.PubMedCrossRefGoogle Scholar
  47. 47.
    Voltarelli JC, et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 2007;297:1568–1576.PubMedCrossRefGoogle Scholar
  48. 48.
    D’Alessandro AM, Kalayoglu M, Hammes R, et al. Diagnosis of intestinal transplant rejection using technetium-99m-DTPA. Transplantation 1994;58:112–113.PubMedGoogle Scholar
  49. 49.
    Sollinger HW, Odorico JS, Knechtle SJ, D’Alessandro AM, Kalayoglu M, Pirsch JD. Experience with 500 simultaneous pancreas-kidney transplants. Ann Surg 1998;228:284–296.PubMedCrossRefGoogle Scholar
  50. 50.
    Gruessner AC, Sutherland DER. Pancreas transplants for United States and non-U.S. cases as reported to the International Pancreas Transplant Registry (IPTR) and to the United Network for Organ Sharing (UNOS). Clinical Transplants 1997. Los Angeles: UCLA Tissue Typing Laboratory; 1998:40–45.Google Scholar
  51. 51.
    Bohman S-O, Wilsczek H, Tyden G, Jaremko G, Lundgren G, Groth CG. Recurrent diabetic nephropathy in renal allografts placed in diabetic patients and protective effect of simultaneous pancreatic transplantation. Transplant Proc 1987;19:2290–2293.PubMedGoogle Scholar
  52. 52.
    Wilczek HE, Jaremko G, Tyden G, Groth CG. Evolution of diabetic nephropathy in kidney grafts: evidence that a simultaneously transplanted pancreas exerts a protective effect. Transplantation 1995;59:51–57.PubMedCrossRefGoogle Scholar
  53. 53.
    el-Gebely S, Hathaway DK, Elmer DS, Gaber LW, Acchiardo S, Gaber AO. An analysis of renal function in pancreas-kidney and diabetic kidney-alone recipients at 2 years following transplantation. Transplantation 1995;59:1410–1415.PubMedCrossRefGoogle Scholar
  54. 54.
    Muller-Felber W, Landgraf R, Scheuer R, et al. Diabetic neuropathy 3 years after successful pancreas and kidney transplantation. Diabetes 1993;42:1482–1486.PubMedCrossRefGoogle Scholar
  55. 55.
    Navarro X, Kennedy WR, Loewensen RB, Sutherland DER. Influence of pancreas transplantation on cardiorespiratory reflexes, nerve conduction, and mortality in diabetes mellitus. Diabetes 1990;39:802–806.PubMedCrossRefGoogle Scholar
  56. 56.
    Wang Q, Klein R, Moss SE, et al. The influence of combined kidney-pancreas transplantation on the progression of diabetic retinopathy: a case series. Ophthalmology 1994;101:1071–1076.PubMedGoogle Scholar
  57. 57.
    Sutherland DER, Kendall DM, Moudry KC, et al. Pancreas transplantation in nonuremic, type 1 diabetic recipients. Surgery 1988;104:453–464.PubMedGoogle Scholar
  58. 58.
    Gross CR, Limwattananon C, Matthees BJ. Quality of life after pancreas transplantation: a review. Clin Transplant 1998;12:351–361.PubMedGoogle Scholar
  59. 59.
    Milde FK, Hart LK, Zehr PS. Pancreatic transplantation: impact on the quality of life of diabetic renal transplant recipients. Diabetes Care 1995;18:93–95.PubMedCrossRefGoogle Scholar
  60. 60.
    Wahoff DC, Papalois BE, Najarian JS, et al. Autologous islet transplantation to prevent diabetes after pancreatic resection. Ann Surg 1995;222:562–579.PubMedCrossRefGoogle Scholar
  61. 61.
    Brendel M, et al. International Islet Transplant Registry Report. Giessen, Germany: University of Giessen; 1999.Google Scholar
  62. 62.
    Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000;343:230–238.PubMedCrossRefGoogle Scholar
  63. 63.
    Ryan EA, Lakey JR, Rajotte RV, et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 2001;50:710–719.PubMedCrossRefGoogle Scholar
  64. 64.
    NCRR launches $10.4 million initiative to create islet cell resource centers. Transplant News 2001;11(20):4.Google Scholar
  65. 65.
    Bertuzzi F, Secchi A, DiCarlo V. Islet transplantation in type 1 diabetics. Transplant Proc 2004;36:603–604.PubMedCrossRefGoogle Scholar
  66. 66.
    Lakey JR, Warnock GL, Rajotte RV, et al. Variables in organ donors that affect the recovery of human islet of Langerhans. Transplantation 1996;61:1047–1053.PubMedCrossRefGoogle Scholar
  67. 67.
    Toso C, Oberholzer J, Ris F, et al. Factors affecting human islet of Langerhans isolation yields. Transplant Proc 2002;34:826–827.PubMedCrossRefGoogle Scholar
  68. 68.
    Lakey JR, Kneteman NM, Rajotte RV, Wu DC, Bigam D, Shapiro AMJ. Effect of core pancreas temperature during cadaveric procurement on human islet isolation and functional viability. Transplantation 2002;73:1106–1110.PubMedCrossRefGoogle Scholar
  69. 69.
    Kawamura T, Kuroda Y, Suzuki Y, Fujiwara H, Yamamoto K, Saitoh Y. A new simple two layer (Euro-Collins’ solution/perfluorochemical) cold storage method for pancreas preservation. Transplant Proc 1989;21(1 pt 2):1376–1377.PubMedGoogle Scholar
  70. 70.
    Fujino Y, Kuroda Y, Suzuki Y, et al. Preservation of canine pancreas for 96 hours by a modified two-layer (UW solution/ perfluorochemical) cold storage method. Transplantation 1991;51:1133–1135.PubMedCrossRefGoogle Scholar
  71. 71.
    Kuroda Y, Kawamura T, Suzuki Y, Fujiwara H, Yamamoto K, Saitoh Y. A new, simple method for cold storage of the pancreas using perfluorochemical. Transplantation 1988;46:457–460.PubMedCrossRefGoogle Scholar
  72. 72.
    Matsumoto S, Rigley TH, Reems JA, Kuroda Y, Stevens RB. Improved islet yields from macaca nemestrina and marginal human pancreata after two-layer method preservation and endogenous trypsin inhibition. Am J Transplant 2003;3:53–63.PubMedCrossRefGoogle Scholar
  73. 73.
    Matsumoto S, Kuroda Y. Perfluorocarbon for organ preservation before transplantation. Transplantation 2002;74:1804–1809.PubMedCrossRefGoogle Scholar
  74. 74.
    Lakey JR, Tsujimura T, Shapiro AM, Kuroda Y. Preservation of the human pancreas before islet isolation using a two-layer (UW solution-perfluorochemical) cold storage method. Transplantation 2002;74:1809–1811.PubMedCrossRefGoogle Scholar
  75. 75.
    Ricordi C, Fraker C, Szust J, et al. Improved human islet isolation outcome from marginal donors following addition of oxygenated perfluorocarbon to the cold-storage solution. Transplantation 2003;75:1524–1527.PubMedCrossRefGoogle Scholar
  76. 76.
    Lowe KC DM, Power JB. Perfluorochemicals: Their applications and benefits to cell culture. Trends Biotechnol 1998;16:272.PubMedCrossRefGoogle Scholar
  77. 77.
    Lowe KC. Perfluorinated blood substitutes and artificial oxygen carriers. Blood Rev 1999;13:171–184.PubMedCrossRefGoogle Scholar
  78. 78.
    D’Alessandro AM, Kalayoglu M, Sollinger FIW, Pirsch JD, Southard JH, Belzer FO. Current status of organ preservation with University of Wisconsin solution. Arch Pathol Lab Med 1991;115:306–310.PubMedGoogle Scholar
  79. 79.
    Palombo JD, Pomposelli JJ, Hirschberg Y, Blackburn GL, Bistrian BR. Glycolytic support of adenine nucleotides in rat liver flush-preserved with UW or Collins’ II. Importance of donor nutritional status. Transplantation 1989;48:901–905.PubMedCrossRefGoogle Scholar
  80. 80.
    Southard JH, van Gulik TM, Ametani MS, et al. Important components of the UW solution. Transplantation 1990;49:251–257.PubMedCrossRefGoogle Scholar
  81. 81.
    Kuroda Y, Fujino Y, Kawamura T, et al. Mechanism of oxygenation of pancreas during preservation by a two-layer (Euro-Collins’ solution/perfluorochemical) cold-storage method. Transplantation 1990;49:694–696.PubMedCrossRefGoogle Scholar
  82. 82.
    Kuroda Y, Fujino Y, Morita A, et al. Successful 96-hour preservation of the canine pancreas. Transpl Int 1992;5(suppl 1):S388–S390.PubMedGoogle Scholar
  83. 83.
    Iwanaga Y, Suzuki Y, Okada Y, et al. Ultrastructural analyses of pancreatic grafts preserved by the two-layer cold-storage method and by simple cold storage in University of Wisconsin solution. Transpl Int 2002;15:425–430.PubMedCrossRefGoogle Scholar
  84. 84.
    Ricordi C, Lacy PE, Finke EH, Olack BJ, Scharp DW. Automated method for isolation of human pancreatic islets. Diabetes 1988;37:413–420.PubMedCrossRefGoogle Scholar
  85. 85.
    Garfinkel MR, Connors M, Ostrega D, Jarosz J, Philipson L, Millis JM. Islet isolation under cGMP conditions: replacing the coil. Transplant Proc 2004;36:1031–1033.PubMedCrossRefGoogle Scholar
  86. 86.
    Hering BJ, Kandaswamy R, Ansite JD, et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 2005;293:830–836.PubMedCrossRefGoogle Scholar
  87. 87.
    Brunicardi FC, Mullen Y. Issues in clinical islet transplantation. Pancreas 1994;9:281–290.PubMedCrossRefGoogle Scholar
  88. 88.
    Larson-Wadd K, Belani KG. Pancreas and islet cell transplantation. Anesthesiol Clin North Am 2004;22:633–674.CrossRefGoogle Scholar
  89. 89.
    Goss JA, Sokes G, Goodpator SE, et al. Pancreatic islet transplantation: the radiologic approach. Transplantation 2003;76:199–203.PubMedCrossRefGoogle Scholar
  90. 90.
    Casey JJ, Lakey JRT, Ryan EA, et al. Portal venous pressure changes after sequential clinical islet transplantation. Transplantation 2002;74:913–915.PubMedCrossRefGoogle Scholar
  91. 91.
    Ryan EA, Lakey JRT, Paty BW, et al. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 2002;21:2148–2157.CrossRefGoogle Scholar
  92. 92.
    Shapiro AMJ, Lakey JRT, Rajotte RV, et al. Portal vein thrombosis after transplantation of partially purified pancreatic islets in a combined human liver/islet transplant. Transplantation 1995;59:1060–1063.PubMedCrossRefGoogle Scholar
  93. 93.
    Hering BJ, Kandaswamy R, Harmon JV, et al. Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody. Am J Transplant 2004;4:390–401.PubMedCrossRefGoogle Scholar
  94. 94.
    Immune Tolerance Network. Preliminary Results of ITN Mul-ticenter Islet Transplant Trial Confirm Potential Patient Benefits, Underscore Steep Learning Curve. In: ITN News and Announcements; 2003.Google Scholar
  95. 95.
    Shapiro AMJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006;355:1318–1330.PubMedCrossRefGoogle Scholar
  96. 96.
    Ryan EA, Paty BW, Senior PA, et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005;54:2060–2069.PubMedCrossRefGoogle Scholar
  97. 97.
    Ryan EA, Shandro T, Green K, et al. Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Diabetes 2004;53:955–962.PubMedCrossRefGoogle Scholar
  98. 98.
    Markmann JF, Deng S, Huang X, et al. Insulin independence following isolated islet transplantation and single islet infusions. Ann Surg 2003;237:741–750.PubMedCrossRefGoogle Scholar
  99. 99.
    Matsumoto S, Okitsu T, Iwanaga Y, et al. Insulin independence after living-donor distal pancreatectomy and islet allotransplantation. Lancet 2005;365:1642–1644.PubMedCrossRefGoogle Scholar
  100. 100.
    Street CN, Sipione S, Helms L, et al. Stem cell-based approaches to solving the problem of tissue supply for islet transplantation in type 1 diabetes. Int J Biochem Cell Biol 2004;36:667–683.PubMedCrossRefGoogle Scholar
  101. 101.
    deVos P, Hamel AF, Tatarkiewicz K. Considerations for successful transplantation of encapsulated pancreatic islets. Diabetologia 2002;45:159–173.CrossRefGoogle Scholar
  102. 102.
    Sun Y, Ma X, Zhao D, Vacek I, Sun AM. Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J Clin Invest 1996;98:1417–1422.PubMedCrossRefGoogle Scholar
  103. 103.
    Chick WL, et al. A hybrid artificial pancreas. Transam Soc Artif Internal Organs 1975;21:8–15.Google Scholar
  104. 104.
    Scharp DW, Mason NS, Sparks RE. Islet immunoisolation: the use of hybrid artificial organs to prevent islet tissue rejection. World J Surg 1984;8:221–229.PubMedCrossRefGoogle Scholar
  105. 105.
    Desai TA, Hansford DJ, Ferrari M. Micromachined interfaces: new approaches in cell immunoisolation and biomolecular separation. Biomol Eng 2000;17:23–36.PubMedCrossRefGoogle Scholar
  106. 106.
    Lim F, Sun AM. Microencapsulated islets as bioartificial endocrine pancreas. Science 1980;210:908–910.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Robert C. Harland
    • 1
    • 2
  • Marc R. Garfinkel
    • 1
  1. 1.Departments of Surgery and MedicineUniversity of Chicago, Center for Advanced MedicineChicagoUSA
  2. 2.Kidney and Pancreas Transplantation, Comer Children’s HospitalUniversity of Chicago, Center for Advanced MedicineChicagoUSA

Personalised recommendations